Skip to main content

Coherus Oncology, Inc.

CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001512762

No open-market purchases or sales by Coherus Oncology, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Coherus Oncology, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
117
−5 vs. Q4 2024
Shares held
62.0M
−3.52M (−5.4%) vs. Q4 2024
Total value
$50.0M
−$40.4M (−44.7%) vs. Q4 2024
New holders
13
40 more added
Sold out
18
32 more reduced

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CHRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 117 institutions
Q1 2021: 205 institutionsQ2 2021: 188 institutionsQ3 2021: 188 institutionsQ4 2021: 201 institutionsQ1 2022: 184 institutionsQ2 2022: 176 institutionsQ3 2022: 174 institutionsQ4 2022: 161 institutionsQ1 2023: 163 institutionsQ2 2023: 161 institutionsQ3 2023: 169 institutionsQ4 2023: 156 institutionsQ1 2024: 137 institutionsQ2 2024: 135 institutionsQ3 2024: 128 institutionsQ4 2024: 124 institutionsQ1 2025: 117 institutionsQ2 2025: 112 institutionsQ3 2025: 114 institutionsQ4 2025: 128 institutionsQ1 2026: 158 institutionsQ2 2026: 146 institutions
Value heldQ1 2025: $50.0M
Q1 2021: $1.17BQ2 2021: $1.08BQ3 2021: $1.22BQ4 2021: $1.23BQ1 2022: $980.7MQ2 2022: $572.0MQ3 2022: $743.4MQ4 2022: $622.7MQ1 2023: $536.5MQ2 2023: $371.1MQ3 2023: $347.6MQ4 2023: $271.4MQ1 2024: $197.6MQ2 2024: $142.9MQ3 2024: $79.9MQ4 2024: $90.5MQ1 2025: $50.0MQ2 2025: $40.4MQ3 2025: $84.6MQ4 2025: $81.1MQ1 2026: $120.8MQ2 2026: $98.5M
Institutions holding CHRS and their total value by quarter
QuarterHoldersValue
Q2 2026146$98.5M
Q1 2026158$120.8M
Q4 2025128$81.1M
Q3 2025114$84.6M
Q2 2025112$40.4M
Q1 2025117$50.0M
Q4 2024124$90.5M
Q3 2024128$79.9M
Q2 2024135$142.9M
Q1 2024137$197.6M
Q4 2023156$271.4M
Q3 2023169$347.6M
Q2 2023161$371.1M
Q1 2023163$536.5M
Q4 2022161$622.7M
Q3 2022174$743.4M
Q2 2022176$572.0M
Q1 2022184$980.7M
Q4 2021201$1.23B
Q3 2021188$1.22B
Q2 2021188$1.08B
Q1 2021205$1.17B

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Coherus Oncology, Inc.; share changes are against Q4 2024.

Institutions holding CHRS in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Tejara Capital Ltd687,218$554.6K0.27%−50,940−6.9%Reduced
Hudson Bay Capital Management LP835,000$673.8K0.00%00.0%Unchanged
Macquarie Group Ltd899,999$726.0K0.00%00.0%Unchanged
Northern Trust Corp947,124$764.3K0.00%−59,381−5.9%Reduced
Charles Schwab Investment Management Inc950,676$767.2K0.00%−26,181−2.7%Reduced
Los Angeles Capital Management LLC991,513$800.2K0.00%−124,629−11.2%Reduced
Citigroup Inc1,021,881$824.7K0.00%+541,280+112.6%Added
C WorldWide Group Holding A/S1,928,464$1.56M0.02%00.0%Unchanged
CM Management, LLC2,147,500$1.73M1.74%+97,500+4.8%Added
State Street Corp2,226,851$1.80M0.00%+49,820+2.3%Added
Geode Capital Management, LLC2,655,500$2.14M0.00%+55,861+2.1%Added
Millennium Management LLC2,899,952$2.34M0.00%+1,850,349+176.3%Added
Kohlberg Kravis Roberts & Co. L.P.3,036,076$2.41M0.05%00.0%Unchanged
Tang Capital Management LLC5,097,362$4.11M0.23%+1,447,362+39.7%Added
Rubric Capital Management LP5,258,754$4.24M0.08%00.0%Unchanged
BlackRock, Inc.10,978,359$8.86M0.00%−97,556−0.9%Reduced
Vanguard Group Inc11,151,905$9.00M0.00%−2,4710.0%Reduced
Point72 Asset Management, L.P.0$00.00%−5,283,292−100.0%Sold out
Disciplined Growth Investors Inc0$00.00%−566,746−100.0%Sold out
Two Sigma Investments, LP0$00.00%−134,138−100.0%Sold out
Savant Capital, LLC0$00.00%−93,984−100.0%Sold out
Birchview Capital, LP0$00.00%−82,000−100.0%Sold out
MetLife Investment Management0$00.00%−73,099−100.0%Sold out
International Assets Investment Management, LLC0$00.00%−45,606−100.0%Sold out
Stephenson National Bank & Trust0$00.00%−25,000−100.0%Sold out
Bank of Montreal0$00.00%−24,690−100.0%Sold out
Jane Street Group, LLC0$00.00%−22,246−100.0%Sold out
Bayesian Capital Management, LP0$00.00%−14,100−100.0%Sold out
Ethic Inc.0$00.00%−11,397−100.0%Sold out
Patriot Financial Group Insurance Agency, LLC0$00.00%−10,169−100.0%Sold out
Mariner, LLC0$00.00%−10,000−100.0%Sold out
Baader Bank INC0$00.00%−10,571−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−743−100.0%Sold out
Larson Financial Group LLC0$00.00%−147−100.0%Sold out
R Squared Ltd0$00.00%−140−100.0%Sold out
Nuveen Asset Management, LLC––––Not filed
TrinityPoint Wealth, LLC––––Not filed